menu
    • menu

    API Export of Vernakalant Hydrochloride obtained from Indian Customs Trade Statistics

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    0

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    0

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 0

    MARKET PLACE

    1

    API

    0

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    3

    FDF Dossiers

    FDF Dossiers

    0

    FDA Orange Book

    FDA (Orange Book)

    1

    Europe

    Europe

    1

    Canada

    Canada

    0

    Australia

    Australia

    1

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    1DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    1

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Finished Drug Prices

    NA

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 748810-28-8, Vernakalant hcl, Brinavess, Kynapid, Vernakalant (hydrochloride), Rsd1235
    Molecular Formula
    C20H32ClNO4
    Molecular Weight
    385.9  g/mol
    InChI Key
    JMHYCBFEEFHTMK-IIUXMCBISA-N
    FDA UNII
    7G4J1ZD9UQ
    Vernakalant Hydrochloride
    1 2D Structure

    Vernakalant Hydrochloride

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol;hydrochloride
    2.1.2 InChI
    InChI=1S/C20H31NO4.ClH/c1-23-19-8-7-15(13-20(19)24-2)10-12-25-18-6-4-3-5-17(18)21-11-9-16(22)14-21;/h7-8,13,16-18,22H,3-6,9-12,14H2,1-2H3;1H/t16-,17-,18-;/m1./s1
    2.1.3 InChI Key
    JMHYCBFEEFHTMK-IIUXMCBISA-N
    2.1.4 Canonical SMILES
    COC1=C(C=C(C=C1)CCOC2CCCCC2N3CCC(C3)O)OC.Cl
    2.1.5 Isomeric SMILES
    COC1=C(C=C(C=C1)CCO[C@@H]2CCCC[C@H]2N3CC[C@H](C3)O)OC.Cl
    2.2 Other Identifiers
    2.2.1 UNII
    7G4J1ZD9UQ
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Rsd 1235

    2. Rsd-1235

    3. Rsd1235

    4. Vernakalant

    2.3.2 Depositor-Supplied Synonyms

    1. 748810-28-8

    2. Vernakalant Hcl

    3. Brinavess

    4. Kynapid

    5. Vernakalant (hydrochloride)

    6. Rsd1235

    7. Vernakalant Hydrochloride [usan]

    8. Rsd-1235

    9. 7g4j1zd9uq

    10. (3r)-1-((1r,2r)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)pyrrolidin-3-ol Hydrochloride

    11. Vernakalant Hydrochloride (usan)

    12. Rsd 1235

    13. Unii-7g4j1zd9uq

    14. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol Hydrochloride

    15. Schembl439679

    16. Chembl2107383

    17. Dtxsid30976007

    18. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol;hydrochloride

    19. Yeb81028

    20. Vernakalant Hydrochloride [mi]

    21. Cs-0799

    22. Mk-6621

    23. Vernakalant Hydrochloride [mart.]

    24. As-58436

    25. Hy-14183

    26. Vernakalant Hydrochloride [who-dd]

    27. Vernakalant Hydrochloride [ema Epar]

    28. C76396

    29. D06665

    30. A915186

    31. Q27268233

    32. Rsd1235 Hydrochloride;rsd 1235 Hydrochloride;rsd-1235 Hydrochloride

    33. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol Hydrochloride

    34. 1-{2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl}pyrrolidin-3-ol--hydrogen Chloride (1/1)

    35. (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol Monohydrochloride

    36. 3-pyrrolidinol, 1-((1r,2r)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)-, Hydrochloride, (3r)-

    37. 605683-48-5

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 385.9 g/mol
    Molecular Formula C20H32ClNO4
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count7
    Exact Mass385.2019862 g/mol
    Monoisotopic Mass385.2019862 g/mol
    Topological Polar Surface Area51.2 Ų
    Heavy Atom Count26
    Formal Charge0
    Complexity394
    Isotope Atom Count0
    Defined Atom Stereocenter Count3
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Indication

    Rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults:

    - for non-surgery patients: atrial fibrillation < /= 7 days duration;

    - for post-cardiac surgery patients: atrial fibrillation < /= 3 days duration.

    5 Pharmacology and Biochemistry
    5.1 ATC Code

    C01BG11

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Market Place

    Do you need sourcing support? Ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search